{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:01:56Z","timestamp":1789142516217,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immuno-inflammation has been shown to play a pivotal role in the pathogenesis of moyamoya disease (MMD). However, how did circulating Treg\/Th17 cells involve in MMD patients remains unclear. 26 MMD, 21 atherothrombotic stroke, and 32 healthy controls were enrolled in this study. MMD patients have a significantly higher percentage of circulating Treg and Th17 cells as well as their dominantly secreting cytokines than other groups (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), whereas no difference was found in the ratio of Treg\/Th17 between patients in MMD and atherothrombotic stroke group or control subjects (<jats:italic>P<\/jats:italic>\u2009=\u20090.244). However, the increased Treg in MMD patients which were enriched with FrIII Treg cells had deficient suppressive functions (<jats:italic>P<\/jats:italic>\u2009=\u20090.0017) compared to healthy volunteers. There was a positive correlation between Treg or TGF-\u03b2 and MMD Suzuki\u2019s stage. And the level of circulating Treg was as an independent factor associated with MMD stage. Besides, TGF-\u03b2 was also correlated with the increased expression of VEGF in MMD patients. Our findings indicated an important involvement of circulating Treg in the pathogenic development of MMD and TGF-\u03b2 in Treg induced VEGF.<\/jats:p>","DOI":"10.1038\/s41598-017-03278-8","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T11:03:56Z","timestamp":1496401436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Association of increased Treg and Th17 with pathogenesis of moyamoya disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Leihua","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"3278_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki, J. & Takaku, A. Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Archives of neurology 20, 288\u2013299, doi:10.1001\/archneur.1969.00480090076012 (1969).","journal-title":"Archives of neurology"},{"key":"3278_CR2","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/01.STR.24.12.1960","volume":"24","author":"J Masuda","year":"1993","unstructured":"Masuda, J., Ogata, J. & Yutani, C. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 24, 1960\u20131967, doi:10.1161\/01.STR.24.12.1960 (1993).","journal-title":"Stroke"},{"key":"3278_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fneur.2013.00105","volume":"4","author":"AM Young","year":"2013","unstructured":"Young, A. M., Karri, S. K., Ogilvy, C. S. & Zhao, N. Is there a role for treating inflammation in moyamoya disease?: a review of histopathology, genetics, and signaling cascades. Front neurol 4, 105, doi:10.3389\/fneur.2013.00105 (2013).","journal-title":"Front neurol"},{"key":"3278_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11910-013-0423-7","volume":"14","author":"A Kronenburg","year":"2014","unstructured":"Kronenburg, A., Braun, K. P., van der Zwan, A. & Klijn, C. J. Recent advances in moyamoya disease: pathophysiology and treatment. Curr Neurol Neurosci Rep 14, 423, doi:10.1007\/s11910-013-0423-7 (2014).","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3278_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","volume":"126","author":"MM Curtis","year":"2009","unstructured":"Curtis, M. M. & Way, S. S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126, 177\u2013185, doi:10.1111\/j.1365-2567.2008.03017.x (2009).","journal-title":"Immunology"},{"key":"3278_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cyto.2014.10.010","volume":"71","author":"P Kumar","year":"2015","unstructured":"Kumar, P. & Subramaniyam, G. Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes. Cytokine 71, 366\u2013376, doi:10.1016\/j.cyto.2014.10.010 (2015).","journal-title":"Cytokine"},{"key":"3278_CR7","doi-asserted-by":"publisher","first-page":"e1004456","DOI":"10.1371\/journal.ppat.1004456","volume":"10","author":"N Whibley","year":"2014","unstructured":"Whibley, N. & Gaffen, S. L. Brothers in arms: Th17 and Treg responses in Candida albicans immunity. PLoS Pathog 10, e1004456, doi:10.1371\/journal.ppat.1004456 (2014).","journal-title":"PLoS Pathog"},{"key":"3278_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cyto.2015.07.005","volume":"76","author":"P Pandiyan","year":"2015","unstructured":"Pandiyan, P. & Zhu, J. Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells. Cytokine 76, 13\u201324, doi:10.1016\/j.cyto.2015.07.005 (2015).","journal-title":"Cytokine"},{"key":"3278_CR9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara, M. et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899\u2013911, doi:10.1016\/j.immuni.2009.03.019 (2009).","journal-title":"Immunity"},{"key":"3278_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5483\/BMBRep.2008.41.4.278","volume":"41","author":"M Shibuya","year":"2008","unstructured":"Shibuya, M. Vascular endothelial growth factor-dependent and-independent regulation of angiogenesis. BMB reports 41, 278\u2013286, doi:10.5483\/BMBRep.2008.41.4.278 (2008).","journal-title":"BMB reports"},{"key":"3278_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10169","volume":"475","author":"A Facciabene","year":"2011","unstructured":"Facciabene, A. et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 475, 226\u2013230, doi:10.1038\/nature10169 (2011).","journal-title":"Nature"},{"key":"3278_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1080\/02841860701233443","volume":"46","author":"S Gupta","year":"2007","unstructured":"Gupta, S., Joshi, K., Wig, J. D. & Arora, S. K. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis. Acta Oncol 46, 792\u2013797, doi:10.1080\/02841860701233443 (2007).","journal-title":"Acta Oncol"},{"key":"3278_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2176\/nmc.ra.2014-0307","volume":"55","author":"M Fujimura","year":"2015","unstructured":"Fujimura, M. & Tominaga, T. Diagnosis of moyamoya disease: international standard and regional differences. Neurol Med Chir 55, 189\u2013193, doi:10.2176\/nmc.ra.2014-0307 (2015).","journal-title":"Neurol Med Chir"},{"key":"3278_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch, E. C. et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 44, 870\u2013947, doi:10.1161\/STR.0b013e318284056a (2013).","journal-title":"Stroke"},{"key":"3278_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2007.01.025","volume":"322","author":"K Venken","year":"2007","unstructured":"Venken, K. et al. A CFSE based assay for measuring CD4+ CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 322, 1\u201311, doi:10.1016\/j.jim.2007.01.025 (2007).","journal-title":"J Immunol Methods"},{"key":"3278_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10143-007-0102-8","volume":"31","author":"S Sakamoto","year":"2008","unstructured":"Sakamoto, S. et al. Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease. Neurosurg Rev 31, 77\u201381, doi:10.1007\/s10143-007-0102-8 (2008).","journal-title":"Neurosurg Rev"},{"key":"3278_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ni.1818","volume":"11","author":"K Wing","year":"2010","unstructured":"Wing, K. & Sakaguchi, S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Iimmunol 11, 7\u201313, doi:10.1038\/ni.1818 (2010).","journal-title":"Nat Iimmunol"},{"key":"3278_CR18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775\u2013787, doi:10.1016\/j.cell.2008.05.009 (2008).","journal-title":"Cell"},{"key":"3278_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/immu.200390024","volume":"33","author":"D Cao","year":"2003","unstructured":"Cao, D. et al. Isolation and functional characterization of regulatory CD25 bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33, 215\u2013223, doi:10.1002\/immu.200390024 (2003).","journal-title":"Eur J Immunol"},{"key":"3278_CR20","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","volume":"172","author":"IM de Kleer","year":"2004","unstructured":"de Kleer, I. M. et al. CD4+ CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172, 6435\u20136443, doi:10.4049\/jimmunol.172.10.6435 (2004).","journal-title":"J Immunol"},{"key":"3278_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","volume":"174","author":"H Sugiyama","year":"2005","unstructured":"Sugiyama, H. et al. Dysfunctional blood and target tissue CD4+ CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174, 164\u2013173, doi:10.4049\/jimmunol.174.1.164 (2005).","journal-title":"J Immunol"},{"key":"3278_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","volume":"54","author":"S Lindley","year":"2005","unstructured":"Lindley, S. et al. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 54, 92\u201399, doi:10.2337\/diabetes.54.1.92 (2005).","journal-title":"Diabetes"},{"key":"3278_CR23","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta, V., Baecher-Allan, C., Weiner, H. L. & Hafler, D. A. Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199, 971\u2013979, doi:10.1084\/jem.20031579 (2004).","journal-title":"J Exp Med"},{"key":"3278_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","volume":"21","author":"X Zhou","year":"2009","unstructured":"Zhou, X., Bailey-Bucktrout, S., Jeker, L. T. & Bluestone, J. A. Plasticity of CD4+ FoxP3+ T cells. Curr Opin Immunol 21, 281\u2013285, doi:10.1016\/j.coi.2009.05.007 (2009).","journal-title":"Curr Opin Immunol"},{"key":"3278_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","volume":"29","author":"XO Yang","year":"2008","unstructured":"Yang, X. O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44\u201356, doi:10.1016\/j.immuni.2008.05.007 (2008).","journal-title":"Immunity"},{"key":"3278_CR26","first-page":"223","volume":"8","author":"P Kidd","year":"2003","unstructured":"Kidd, P. Th1\/Th2 Balance: The Hypothesis, its Limitations, and Implications for Health and Disease. Altern Med Rev 8, 223\u2013246 (2003).","journal-title":"Altern Med Rev"},{"key":"3278_CR27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.141.3.827","volume":"141","author":"YP Huang","year":"1988","unstructured":"Huang, Y. P., Perrin, L. H., Miescher, P. A. & Zubler, R. H. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 141, 827\u2013833 (1988).","journal-title":"J Immunol"},{"key":"3278_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar2440","volume":"10","author":"DS Pisetsky","year":"2008","unstructured":"Pisetsky, D. S., Erlandsson-Harris, H. & Andersson, U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther 10, 209, doi:10.1186\/ar2440 (2008).","journal-title":"Arthritis Res Ther"},{"key":"3278_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/STROKEAHA.108.529420","volume":"40","author":"N Rafat","year":"2009","unstructured":"Rafat, N., Beck, G., Pena-Tapia, P. G., Schmiedek, P. & Vajkoczy, P. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke 40, 432\u2013438, doi:10.1161\/STROKEAHA.108.529420 (2009).","journal-title":"Stroke"},{"key":"3278_CR30","doi-asserted-by":"publisher","first-page":"623759","DOI":"10.1155\/2014\/623759","volume":"2014","author":"B Yang","year":"2014","unstructured":"Yang, B. et al. The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. Mediators Inflamm 2014, 623759\u201312, doi:10.1155\/2014\/623759 (2014).","journal-title":"Mediators Inflamm"},{"key":"3278_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10555-011-9281-4","volume":"30","author":"E Tartour","year":"2011","unstructured":"Tartour, E. et al. Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer Metastasis Rev 30, 83\u201395, doi:10.1007\/s10555-011-9281-4 (2011).","journal-title":"Cancer Metastasis Rev"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03278-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T21:50:47Z","timestamp":1692827447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03278-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3278"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03278-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]},"assertion":[{"value":"31 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3071"}}